Financials
Takeda Pharmaceutical: FYE Mar 2026 and ten years of results (46 metrics)
FYE Mar 2026 · Revenue¥4.51tnYoY −1.7%
FYE Mar 2026 · Operating profit¥6.2bnYoY −98.2%
FYE Mar 2026 · Net profit-¥152bnYoY −241.2%
FYE Mar 2025 · Equity ratio48.7%YoY +0.5pp
FYE Mar 2026 · Group employees47,029YoY −426
| Fiscal year | Revenue | YoY | Operating profit | YoY | Margin | Net profit | Chief executive | That year |
|---|---|---|---|---|---|---|---|---|
| FYE Mar 2017Consolidated | ¥1.73tn | n/a | n/a | n/a | n/a | ¥115bn | Christophe Weber | — |
| FYE Mar 2018Consolidated | ¥1.77tn | +2.2% | ¥242bn | n/a | 13.7% | ¥187bn | Christophe Weber | ARIAD Pharmaceuticals acquired by tender offer |
| FYE Mar 2019Consolidated | ¥2.10tn | +18.5% | ¥238bn | −1.7% | 11.3% | ¥135bn | Christophe Weber | American depositary shares listed on the New York Stock Exchange |
| FYE Mar 2020Consolidated | ¥3.29tn | +56.9% | ¥100bn | −57.8% | 3.1% | ¥44bn | Christophe Weber | Shire acquired for about ¥6.8 trillion |
| FYE Mar 2021Consolidated | ¥3.20tn | −2.8% | ¥509bn | +407.2% | 15.9% | ¥376bn | Christophe Weber | Consolidated revenue reaches ¥3,291.2 billion |
| FYE Mar 2022Consolidated | ¥3.57tn | +11.6% | ¥461bn | −9.5% | 12.9% | ¥230bn | Christophe Weber | — |
| FYE Mar 2023Consolidated | ¥4.03tn | +12.8% | ¥491bn | +6.4% | 12.2% | ¥317bn | Christophe Weber | — |
| FYE Mar 2024Consolidated | ¥4.26tn | +5.9% | ¥214bn | −56.4% | 5.0% | ¥144bn | Christophe Weber | — |
| FYE Mar 2025Consolidated | ¥4.58tn | +7.5% | ¥343bn | +60.0% | 7.5% | ¥108bn | Christophe Weber | Restructuring costing ¥140 billion a year announced |
| FYE Mar 2026Consolidated | ¥4.51tn | −1.7% | ¥6.2bn | −98.2% | 0.1% | -¥152bn | Christophe Weber | — |
How it compares
Takeda Pharmaceutical¥4.51tnFY2025Operating margin 0.1%
Otsuka Holdings¥2.47tnFY2025Operating margin 19.4%Astellas Pharma¥2.14tnFY2025Operating margin 17.9%Daiichi Sankyo¥2.12tnFY2025Operating margin 10.8%Chugai Pharmaceutical¥1.26tnFY2025Operating margin 47.6%Eisai¥825bnFY2025Operating margin 5.3%Yamanouchi Pharmaceutical Co., Ltd.Dissolved 2005
Shionogi¥500bnFY2025Operating margin 33.4%Sumitomo Pharma¥453bnFY2025Operating margin 23.7%Mitsubishi Tanabe Pharma CorporationDissolved 2020
Income statement Revenue, costs, each level of profit and the margins they leave
Where the revenue goes
¥ bnMargins
%Revenue net sales, operating revenue
FYE Mar 2026 ¥4.51tn
CAGR · 10 yrs +11.2%
| Fiscal year | Revenue ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 1,732 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 1,771 | +2.2% | Cons. · IFRS |
| FYE Mar 2019 | 2,097 | +18.5% | Cons. · IFRS |
| FYE Mar 2020 | 3,291 | +56.9% | Cons. · IFRS |
| FYE Mar 2021 | 3,198 | −2.8% | Cons. · IFRS |
| FYE Mar 2022 | 3,569 | +11.6% | Cons. · IFRS |
| FYE Mar 2023 | 4,027 | +12.8% | Cons. · IFRS |
| FYE Mar 2024 | 4,264 | +5.9% | Cons. · IFRS |
| FYE Mar 2025 | 4,582 | +7.5% | Cons. · IFRS |
| FYE Mar 2026 | 4,506 | −1.7% | Cons. · IFRS |
Cost of sales
FYE Mar 2026 ¥1.57tn
CAGR · 9 yrs +15.5%
| Fiscal year | Cost of sales ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 496 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 652 | +31.4% | Cons. · IFRS |
| FYE Mar 2020 | 1,090 | +67.2% | Cons. · IFRS |
| FYE Mar 2021 | 994 | −8.8% | Cons. · IFRS |
| FYE Mar 2022 | 1,107 | +11.3% | Cons. · IFRS |
| FYE Mar 2023 | 1,244 | +12.4% | Cons. · IFRS |
| FYE Mar 2024 | 1,427 | +14.7% | Cons. · IFRS |
| FYE Mar 2025 | 1,580 | +10.8% | Cons. · IFRS |
| FYE Mar 2026 | 1,572 | −0.5% | Cons. · IFRS |
Gross profit
FYE Mar 2026 ¥2.93tn
CAGR · 9 yrs +11.0%
| Fiscal year | Gross profit ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 1,275 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 1,445 | +13.4% | Cons. · IFRS |
| FYE Mar 2020 | 2,201 | +52.3% | Cons. · IFRS |
| FYE Mar 2021 | 2,204 | +0.1% | Cons. · IFRS |
| FYE Mar 2022 | 2,462 | +11.7% | Cons. · IFRS |
| FYE Mar 2023 | 2,783 | +13.0% | Cons. · IFRS |
| FYE Mar 2024 | 2,837 | +1.9% | Cons. · IFRS |
| FYE Mar 2025 | 3,001 | +5.8% | Cons. · IFRS |
| FYE Mar 2026 | 2,934 | −2.2% | Cons. · IFRS |
SG&A selling, general and administrative expenses
FYE Mar 2026 ¥1.08tn
CAGR · 9 yrs +7.1%
| Fiscal year | SG&A ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 628 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 718 | +14.2% | Cons. · IFRS |
| FYE Mar 2020 | 965 | +34.4% | Cons. · IFRS |
| FYE Mar 2021 | 876 | −9.2% | Cons. · IFRS |
| FYE Mar 2022 | 886 | +1.2% | Cons. · IFRS |
| FYE Mar 2023 | 997 | +12.5% | Cons. · IFRS |
| FYE Mar 2024 | 1,054 | +5.7% | Cons. · IFRS |
| FYE Mar 2025 | 1,105 | +4.8% | Cons. · IFRS |
| FYE Mar 2026 | 1,084 | −1.9% | Cons. · IFRS |
Operating profit
FYE Mar 2026 ¥6.2bn
CAGR · 9 yrs −36.7%
| Fiscal year | Operating profit ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 242 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 238 | −1.7% | Cons. · IFRS |
| FYE Mar 2020 | 100 | −57.8% | Cons. · IFRS |
| FYE Mar 2021 | 509 | +407.2% | Cons. · IFRS |
| FYE Mar 2022 | 461 | −9.5% | Cons. · IFRS |
| FYE Mar 2023 | 491 | +6.4% | Cons. · IFRS |
| FYE Mar 2024 | 214 | −56.4% | Cons. · IFRS |
| FYE Mar 2025 | 343 | +60.0% | Cons. · IFRS |
| FYE Mar 2026 | 6.2 | −98.2% | Cons. · IFRS |
Non-operating income
FYE Mar 2026 ¥211bn
CAGR · 9 yrs +23.3%
| Fiscal year | Non-operating income ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 39.5 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 16.8 | −57.4% | Cons. · IFRS |
| FYE Mar 2020 | 27.8 | +65.2% | Cons. · IFRS |
| FYE Mar 2021 | 106 | +279.1% | Cons. · IFRS |
| FYE Mar 2022 | 23.7 | −77.5% | Cons. · IFRS |
| FYE Mar 2023 | 62.9 | +165.5% | Cons. · IFRS |
| FYE Mar 2024 | 52.1 | −17.2% | Cons. · IFRS |
| FYE Mar 2025 | 46.5 | −10.6% | Cons. · IFRS |
| FYE Mar 2026 | 211 | +353.7% | Cons. · IFRS |
Non-operating expenses
FYE Mar 2026 ¥358bn
CAGR · 9 yrs +35.3%
| Fiscal year | Non-operating expenses ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 31.9 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 83.3 | +160.9% | Cons. · IFRS |
| FYE Mar 2020 | 165 | +98.1% | Cons. · IFRS |
| FYE Mar 2021 | 249 | +50.7% | Cons. · IFRS |
| FYE Mar 2022 | 167 | −33.0% | Cons. · IFRS |
| FYE Mar 2023 | 170 | +1.9% | Cons. · IFRS |
| FYE Mar 2024 | 220 | +29.6% | Cons. · IFRS |
| FYE Mar 2025 | 210 | −4.5% | Cons. · IFRS |
| FYE Mar 2026 | 358 | +70.2% | Cons. · IFRS |
Net profit profit attributable to owners of the parent
FYE Mar 2026 -¥152bn
Average · 10 yrs ¥150bn
| Fiscal year | Net profit ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 115 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 187 | +62.6% | Cons. · IFRS |
| FYE Mar 2019 | 135 | −27.7% | Cons. · IFRS |
| FYE Mar 2020 | 44.2 | −67.3% | Cons. · IFRS |
| FYE Mar 2021 | 376 | +749.9% | Cons. · IFRS |
| FYE Mar 2022 | 230 | −38.8% | Cons. · IFRS |
| FYE Mar 2023 | 317 | +37.8% | Cons. · IFRS |
| FYE Mar 2024 | 144 | −54.6% | Cons. · IFRS |
| FYE Mar 2025 | 108 | −25.1% | Cons. · IFRS |
| FYE Mar 2026 | -152 | −241.2% | Cons. · IFRS |
Gross margin
FYE Mar 2026 65.1%
Average · 9 yrs 68.0%
| Fiscal year | Gross margin % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 72.0 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 68.9 | −3.1pp | Cons. · IFRS |
| FYE Mar 2020 | 66.9 | −2.0pp | Cons. · IFRS |
| FYE Mar 2021 | 68.9 | +2.0pp | Cons. · IFRS |
| FYE Mar 2022 | 69.0 | +0.1pp | Cons. · IFRS |
| FYE Mar 2023 | 69.1 | +0.1pp | Cons. · IFRS |
| FYE Mar 2024 | 66.5 | −2.6pp | Cons. · IFRS |
| FYE Mar 2025 | 65.5 | −1.0pp | Cons. · IFRS |
| FYE Mar 2026 | 65.1 | −0.4pp | Cons. · IFRS |
Operating margin
FYE Mar 2026 0.1%
Average · 9 yrs 9.1%
| Fiscal year | Operating margin % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 13.7 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 11.3 | −2.3pp | Cons. · IFRS |
| FYE Mar 2020 | 3.1 | −8.3pp | Cons. · IFRS |
| FYE Mar 2021 | 15.9 | +12.9pp | Cons. · IFRS |
| FYE Mar 2022 | 12.9 | −3.0pp | Cons. · IFRS |
| FYE Mar 2023 | 12.2 | −0.7pp | Cons. · IFRS |
| FYE Mar 2024 | 5.0 | −7.2pp | Cons. · IFRS |
| FYE Mar 2025 | 7.5 | +2.5pp | Cons. · IFRS |
| FYE Mar 2026 | 0.1 | −7.3pp | Cons. · IFRS |
Net margin
FYE Mar 2026 -3.4%
Average · 10 yrs 5.3%
| Fiscal year | Net margin % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 6.6 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 10.6 | +3.9pp | Cons. · IFRS |
| FYE Mar 2019 | 6.4 | −4.1pp | Cons. · IFRS |
| FYE Mar 2020 | 1.3 | −5.1pp | Cons. · IFRS |
| FYE Mar 2021 | 11.8 | +10.4pp | Cons. · IFRS |
| FYE Mar 2022 | 6.4 | −5.3pp | Cons. · IFRS |
| FYE Mar 2023 | 7.9 | +1.4pp | Cons. · IFRS |
| FYE Mar 2024 | 3.4 | −4.5pp | Cons. · IFRS |
| FYE Mar 2025 | 2.4 | −1.0pp | Cons. · IFRS |
| FYE Mar 2026 | -3.4 | −5.7pp | Cons. · IFRS |
Cost-of-sales ratio
FYE Mar 2026 34.9%
Average · 9 yrs 32.0%
| Fiscal year | Cost-of-sales ratio % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 28.0 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 31.1 | +3.1pp | Cons. · IFRS |
| FYE Mar 2020 | 33.1 | +2.0pp | Cons. · IFRS |
| FYE Mar 2021 | 31.1 | −2.0pp | Cons. · IFRS |
| FYE Mar 2022 | 31.0 | −0.1pp | Cons. · IFRS |
| FYE Mar 2023 | 30.9 | −0.1pp | Cons. · IFRS |
| FYE Mar 2024 | 33.5 | +2.6pp | Cons. · IFRS |
| FYE Mar 2025 | 34.5 | +1.0pp | Cons. · IFRS |
| FYE Mar 2026 | 34.9 | +0.4pp | Cons. · IFRS |
SG&A ratio
FYE Mar 2026 24.1%
Average · 9 yrs 27.7%
| Fiscal year | SG&A ratio % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 35.5 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 34.2 | −1.3pp | Cons. · IFRS |
| FYE Mar 2020 | 29.3 | −4.9pp | Cons. · IFRS |
| FYE Mar 2021 | 27.4 | −1.9pp | Cons. · IFRS |
| FYE Mar 2022 | 24.8 | −2.5pp | Cons. · IFRS |
| FYE Mar 2023 | 24.8 | −0.1pp | Cons. · IFRS |
| FYE Mar 2024 | 24.7 | −0.0pp | Cons. · IFRS |
| FYE Mar 2025 | 24.1 | −0.6pp | Cons. · IFRS |
| FYE Mar 2026 | 24.1 | −0.1pp | Cons. · IFRS |
Balance sheet Assets, debt and equity, and what they say about financial strength
What the balance sheet is made of
¥ bnFinancial strength
%Total assets
FYE Mar 2026 ¥15.5tn
CAGR · 10 yrs +15.2%
| Fiscal year | Total assets ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 4,347 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 4,106 | −5.5% | Cons. · IFRS |
| FYE Mar 2019 | 13,793 | +235.9% | Cons. · IFRS |
| FYE Mar 2020 | 12,821 | −7.0% | Cons. · IFRS |
| FYE Mar 2021 | 12,912 | +0.7% | Cons. · IFRS |
| FYE Mar 2022 | 13,178 | +2.1% | Cons. · IFRS |
| FYE Mar 2023 | 13,958 | +5.9% | Cons. · IFRS |
| FYE Mar 2024 | 15,109 | +8.2% | Cons. · IFRS |
| FYE Mar 2025 | 14,248 | −5.7% | Cons. · IFRS |
| FYE Mar 2026 | 15,512 | +8.9% | Cons. · IFRS |
Equity net assets, shareholders' equity
FYE Mar 2026 n/a
CAGR · 9 yrs +17.2%
| Fiscal year | Equity ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 1,949 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 1,997 | +2.5% | Cons. · IFRS |
| FYE Mar 2019 | 5,182 | +159.4% | Cons. · IFRS |
| FYE Mar 2020 | 4,723 | −8.8% | Cons. · IFRS |
| FYE Mar 2021 | 5,173 | +9.5% | Cons. · IFRS |
| FYE Mar 2022 | 5,683 | +9.9% | Cons. · IFRS |
| FYE Mar 2023 | 6,354 | +11.8% | Cons. · IFRS |
| FYE Mar 2024 | 7,273 | +14.5% | Cons. · IFRS |
| FYE Mar 2025 | 6,935 | −4.6% | Cons. · IFRS |
| FYE Mar 2026 | n/a | n/a | Cons. · IFRS |
Interest-bearing debt
FYE Mar 2026 ¥4.88tn
CAGR · 10 yrs +17.5%
| Fiscal year | Interest-bearing debt ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 1,145 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 986 | −13.9% | Cons. · IFRS |
| FYE Mar 2019 | 5,751 | +483.5% | Cons. · IFRS |
| FYE Mar 2020 | 5,093 | −11.4% | Cons. · IFRS |
| FYE Mar 2021 | 4,635 | −9.0% | Cons. · IFRS |
| FYE Mar 2022 | 4,345 | −6.3% | Cons. · IFRS |
| FYE Mar 2023 | 4,382 | +0.8% | Cons. · IFRS |
| FYE Mar 2024 | 4,844 | +10.5% | Cons. · IFRS |
| FYE Mar 2025 | 4,515 | −6.8% | Cons. · IFRS |
| FYE Mar 2026 | 4,882 | +8.1% | Cons. · IFRS |
Short-term borrowings
FYE Mar 2026 ¥512bn
CAGR · 10 yrs −0.7%
| Fiscal year | Short-term borrowings ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 545 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 0.0 | −100.0% | Cons. · IFRS |
| FYE Mar 2019 | 985 | +5471822.2% | Cons. · IFRS |
| FYE Mar 2020 | 587 | −40.4% | Cons. · IFRS |
| FYE Mar 2021 | 22.2 | −96.2% | Cons. · IFRS |
| FYE Mar 2022 | 204 | +820.8% | Cons. · IFRS |
| FYE Mar 2023 | 340 | +66.5% | Cons. · IFRS |
| FYE Mar 2024 | 367 | +8.1% | Cons. · IFRS |
| FYE Mar 2025 | 549 | +49.5% | Cons. · IFRS |
| FYE Mar 2026 | 512 | −6.7% | Cons. · IFRS |
Long-term borrowings
FYE Mar 2026 ¥4.37tn
CAGR · 10 yrs +24.7%
| Fiscal year | Long-term borrowings ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 600 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 986 | +64.3% | Cons. · IFRS |
| FYE Mar 2019 | 4,766 | +383.5% | Cons. · IFRS |
| FYE Mar 2020 | 4,506 | −5.4% | Cons. · IFRS |
| FYE Mar 2021 | 4,613 | +2.4% | Cons. · IFRS |
| FYE Mar 2022 | 4,141 | −10.2% | Cons. · IFRS |
| FYE Mar 2023 | 4,043 | −2.4% | Cons. · IFRS |
| FYE Mar 2024 | 4,477 | +10.7% | Cons. · IFRS |
| FYE Mar 2025 | 3,966 | −11.4% | Cons. · IFRS |
| FYE Mar 2026 | 4,370 | +10.2% | Cons. · IFRS |
Intangible assets
FYE Mar 2026 ¥3.42tn
CAGR · 10 yrs +13.9%
| Fiscal year | Intangible assets ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 1,063 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 1,014 | −4.6% | Cons. · IFRS |
| FYE Mar 2019 | 4,751 | +368.4% | Cons. · IFRS |
| FYE Mar 2020 | 4,171 | −12.2% | Cons. · IFRS |
| FYE Mar 2021 | 3,909 | −6.3% | Cons. · IFRS |
| FYE Mar 2022 | 3,819 | −2.3% | Cons. · IFRS |
| FYE Mar 2023 | 4,270 | +11.8% | Cons. · IFRS |
| FYE Mar 2024 | 4,275 | +0.1% | Cons. · IFRS |
| FYE Mar 2025 | 3,632 | −15.0% | Cons. · IFRS |
| FYE Mar 2026 | 3,419 | −5.8% | Cons. · IFRS |
Goodwill
FYE Mar 2026 ¥5.81tn
CAGR · 10 yrs +21.3%
| Fiscal year | Goodwill ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 1,020 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 1,029 | +0.9% | Cons. · IFRS |
| FYE Mar 2019 | 4,240 | +312.0% | Cons. · IFRS |
| FYE Mar 2020 | 4,013 | −5.4% | Cons. · IFRS |
| FYE Mar 2021 | 4,034 | +0.5% | Cons. · IFRS |
| FYE Mar 2022 | 4,408 | +9.3% | Cons. · IFRS |
| FYE Mar 2023 | 4,791 | +8.7% | Cons. · IFRS |
| FYE Mar 2024 | 5,410 | +12.9% | Cons. · IFRS |
| FYE Mar 2025 | 5,324 | −1.6% | Cons. · IFRS |
| FYE Mar 2026 | 5,809 | +9.1% | Cons. · IFRS |
Equity ratio
FYE Mar 2026 n/a
Average · 9 yrs 43.7%
| Fiscal year | Equity ratio % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 44.8 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 48.6 | +3.8pp | Cons. · IFRS |
| FYE Mar 2019 | 37.6 | −11.1pp | Cons. · IFRS |
| FYE Mar 2020 | 36.8 | −0.7pp | Cons. · IFRS |
| FYE Mar 2021 | 40.1 | +3.2pp | Cons. · IFRS |
| FYE Mar 2022 | 43.1 | +3.1pp | Cons. · IFRS |
| FYE Mar 2023 | 45.5 | +2.4pp | Cons. · IFRS |
| FYE Mar 2024 | 48.1 | +2.6pp | Cons. · IFRS |
| FYE Mar 2025 | 48.7 | +0.5pp | Cons. · IFRS |
| FYE Mar 2026 | n/a | n/a | Cons. · IFRS |
Debt-to-equity ratio D/E ratio
FYE Mar 2026 n/a
Average · 9 yrs 77.1%
| Fiscal year | Debt-to-equity ratio % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 58.7 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 49.3 | −9.4pp | Cons. · IFRS |
| FYE Mar 2019 | 111.0 | +61.6pp | Cons. · IFRS |
| FYE Mar 2020 | 107.8 | −3.2pp | Cons. · IFRS |
| FYE Mar 2021 | 89.6 | −18.2pp | Cons. · IFRS |
| FYE Mar 2022 | 76.5 | −13.1pp | Cons. · IFRS |
| FYE Mar 2023 | 69.0 | −7.5pp | Cons. · IFRS |
| FYE Mar 2024 | 66.6 | −2.4pp | Cons. · IFRS |
| FYE Mar 2025 | 65.1 | −1.5pp | Cons. · IFRS |
| FYE Mar 2026 | n/a | n/a | Cons. · IFRS |
ROE return on equity
FYE Mar 2026 n/a
Average · 9 yrs 4.3%
| Fiscal year | ROE % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 5.9 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 9.4 | +3.5pp | Cons. · IFRS |
| FYE Mar 2019 | 2.6 | −6.7pp | Cons. · IFRS |
| FYE Mar 2020 | 0.9 | −1.7pp | Cons. · IFRS |
| FYE Mar 2021 | 7.3 | +6.3pp | Cons. · IFRS |
| FYE Mar 2022 | 4.0 | −3.2pp | Cons. · IFRS |
| FYE Mar 2023 | 5.0 | +0.9pp | Cons. · IFRS |
| FYE Mar 2024 | 2.0 | −3.0pp | Cons. · IFRS |
| FYE Mar 2025 | 1.6 | −0.4pp | Cons. · IFRS |
| FYE Mar 2026 | n/a | n/a | Cons. · IFRS |
ROA return on assets
FYE Mar 2026 -1.0%
Average · 10 yrs 1.6%
| Fiscal year | ROA % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 2.6 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 4.6 | +1.9pp | Cons. · IFRS |
| FYE Mar 2019 | 1.0 | −3.6pp | Cons. · IFRS |
| FYE Mar 2020 | 0.3 | −0.6pp | Cons. · IFRS |
| FYE Mar 2021 | 2.9 | +2.6pp | Cons. · IFRS |
| FYE Mar 2022 | 1.7 | −1.2pp | Cons. · IFRS |
| FYE Mar 2023 | 2.3 | +0.5pp | Cons. · IFRS |
| FYE Mar 2024 | 1.0 | −1.3pp | Cons. · IFRS |
| FYE Mar 2025 | 0.8 | −0.2pp | Cons. · IFRS |
| FYE Mar 2026 | -1.0 | −1.7pp | Cons. · IFRS |
Asset turnover
FYE Mar 2026 0.29×
CAGR · 10 yrs −3.5%
| Fiscal year | Asset turnover × | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 0.40 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 0.43 | +8.2% | Cons. · IFRS |
| FYE Mar 2019 | 0.15 | −64.7% | Cons. · IFRS |
| FYE Mar 2020 | 0.26 | +68.8% | Cons. · IFRS |
| FYE Mar 2021 | 0.25 | −3.5% | Cons. · IFRS |
| FYE Mar 2022 | 0.27 | +9.4% | Cons. · IFRS |
| FYE Mar 2023 | 0.29 | +6.5% | Cons. · IFRS |
| FYE Mar 2024 | 0.28 | −2.2% | Cons. · IFRS |
| FYE Mar 2025 | 0.32 | +13.9% | Cons. · IFRS |
| FYE Mar 2026 | 0.29 | −9.7% | Cons. · IFRS |
Cash flow statement Cash from operations, investment and financing, and what is left on hand
The three cash flows
¥ bnCash against debt
¥ bnOperating cash flow
FYE Mar 2026 ¥1.04tn
CAGR · 10 yrs +16.6%
| Fiscal year | Operating cash flow ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 261 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 378 | +44.6% | Cons. · IFRS |
| FYE Mar 2019 | 328 | −13.1% | Cons. · IFRS |
| FYE Mar 2020 | 670 | +103.9% | Cons. · IFRS |
| FYE Mar 2021 | 1,011 | +50.9% | Cons. · IFRS |
| FYE Mar 2022 | 1,123 | +11.1% | Cons. · IFRS |
| FYE Mar 2023 | 977 | −13.0% | Cons. · IFRS |
| FYE Mar 2024 | 716 | −26.7% | Cons. · IFRS |
| FYE Mar 2025 | 1,057 | +47.6% | Cons. · IFRS |
| FYE Mar 2026 | 1,041 | −1.5% | Cons. · IFRS |
Investing cash flow
FYE Mar 2026 -¥369bn
Average · 10 yrs -¥490bn
| Fiscal year | Investing cash flow ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | -656 | n/a | Cons. · IFRS |
| FYE Mar 2018 | -93.3 | n/a | Cons. · IFRS |
| FYE Mar 2019 | -2,836 | n/a | Cons. · IFRS |
| FYE Mar 2020 | 292 | n/a | Cons. · IFRS |
| FYE Mar 2021 | 394 | +34.7% | Cons. · IFRS |
| FYE Mar 2022 | -198 | −150.3% | Cons. · IFRS |
| FYE Mar 2023 | -607 | n/a | Cons. · IFRS |
| FYE Mar 2024 | -464 | n/a | Cons. · IFRS |
| FYE Mar 2025 | -367 | n/a | Cons. · IFRS |
| FYE Mar 2026 | -369 | n/a | Cons. · IFRS |
Financing cash flow
FYE Mar 2026 -¥497bn
Average · 10 yrs -¥257bn
| Fiscal year | Financing cash flow ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 290 | n/a | Cons. · IFRS |
| FYE Mar 2018 | -326 | −212.5% | Cons. · IFRS |
| FYE Mar 2019 | 2,946 | n/a | Cons. · IFRS |
| FYE Mar 2020 | -1,005 | −134.1% | Cons. · IFRS |
| FYE Mar 2021 | -1,088 | n/a | Cons. · IFRS |
| FYE Mar 2022 | -1,070 | n/a | Cons. · IFRS |
| FYE Mar 2023 | -709 | n/a | Cons. · IFRS |
| FYE Mar 2024 | -354 | n/a | Cons. · IFRS |
| FYE Mar 2025 | -751 | n/a | Cons. · IFRS |
| FYE Mar 2026 | -497 | n/a | Cons. · IFRS |
Cash and equivalents
FYE Mar 2026 ¥595bn
CAGR · 10 yrs +7.2%
| Fiscal year | Cash and equivalents ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 319 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 295 | −7.8% | Cons. · IFRS |
| FYE Mar 2019 | 702 | +138.4% | Cons. · IFRS |
| FYE Mar 2020 | 638 | −9.2% | Cons. · IFRS |
| FYE Mar 2021 | 966 | +51.5% | Cons. · IFRS |
| FYE Mar 2022 | 850 | −12.1% | Cons. · IFRS |
| FYE Mar 2023 | 534 | −37.2% | Cons. · IFRS |
| FYE Mar 2024 | 458 | −14.2% | Cons. · IFRS |
| FYE Mar 2025 | 385 | −15.9% | Cons. · IFRS |
| FYE Mar 2026 | 595 | +54.5% | Cons. · IFRS |
Free cash flow
FYE Mar 2026 ¥672bn
Average · 10 yrs ¥266bn
| Fiscal year | FCF ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | -394 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 285 | n/a | Cons. · IFRS |
| FYE Mar 2019 | -2,507 | −981.2% | Cons. · IFRS |
| FYE Mar 2020 | 962 | n/a | Cons. · IFRS |
| FYE Mar 2021 | 1,404 | +46.0% | Cons. · IFRS |
| FYE Mar 2022 | 925 | −34.1% | Cons. · IFRS |
| FYE Mar 2023 | 370 | −60.0% | Cons. · IFRS |
| FYE Mar 2024 | 252 | −31.8% | Cons. · IFRS |
| FYE Mar 2025 | 690 | +173.3% | Cons. · IFRS |
| FYE Mar 2026 | 672 | −2.6% | Cons. · IFRS |
Operating cash flow margin
FYE Mar 2026 23.1%
Average · 10 yrs 22.3%
| Fiscal year | OCF margin % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 15.1 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 21.3 | +6.3pp | Cons. · IFRS |
| FYE Mar 2019 | 15.7 | −5.7pp | Cons. · IFRS |
| FYE Mar 2020 | 20.3 | +4.7pp | Cons. · IFRS |
| FYE Mar 2021 | 31.6 | +11.3pp | Cons. · IFRS |
| FYE Mar 2022 | 31.5 | −0.1pp | Cons. · IFRS |
| FYE Mar 2023 | 24.3 | −7.2pp | Cons. · IFRS |
| FYE Mar 2024 | 16.8 | −7.5pp | Cons. · IFRS |
| FYE Mar 2025 | 23.1 | +6.3pp | Cons. · IFRS |
| FYE Mar 2026 | 23.1 | −0.0pp | Cons. · IFRS |
Net cash
FYE Mar 2026 -¥4.29tn
Average · 10 yrs -¥3.48tn
| Fiscal year | Net cash ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | -825 | n/a | Cons. · IFRS |
| FYE Mar 2018 | -691 | n/a | Cons. · IFRS |
| FYE Mar 2019 | -5,049 | n/a | Cons. · IFRS |
| FYE Mar 2020 | -4,456 | n/a | Cons. · IFRS |
| FYE Mar 2021 | -3,669 | n/a | Cons. · IFRS |
| FYE Mar 2022 | -3,496 | n/a | Cons. · IFRS |
| FYE Mar 2023 | -3,849 | n/a | Cons. · IFRS |
| FYE Mar 2024 | -4,386 | n/a | Cons. · IFRS |
| FYE Mar 2025 | -4,130 | n/a | Cons. · IFRS |
| FYE Mar 2026 | -4,287 | n/a | Cons. · IFRS |
Shares and share price Shares outstanding, price, market capitalisation and the valuation multiples
Market capitalisation
FYE Mar 2026 n/a
Change · 9 yrs +¥2.90tn
| Fiscal year | Market capitalisation ¥ bn | Basis |
|---|---|---|
| FYE Mar 2017 | 4,130 | n/a |
| FYE Mar 2018 | 4,128 | n/a |
| FYE Mar 2019 | 7,086 | n/a |
| FYE Mar 2020 | 5,213 | n/a |
| FYE Mar 2021 | 6,299 | n/a |
| FYE Mar 2022 | 5,541 | n/a |
| FYE Mar 2023 | 6,885 | n/a |
| FYE Mar 2024 | 6,616 | n/a |
| FYE Mar 2025 | 7,026 | n/a |
| FYE Mar 2026 | n/a | n/a |
Share price year-end close
FYE Mar 2026 n/a
Change · 9 yrs −808¥
| Fiscal year | Share price ¥ | Basis |
|---|---|---|
| FYE Mar 2017 | 5,224 | n/a |
| FYE Mar 2018 | 5,194 | n/a |
| FYE Mar 2019 | 4,528 | n/a |
| FYE Mar 2020 | 3,307 | n/a |
| FYE Mar 2021 | 3,996 | n/a |
| FYE Mar 2022 | 3,502 | n/a |
| FYE Mar 2023 | 4,351 | n/a |
| FYE Mar 2024 | 4,181 | n/a |
| FYE Mar 2025 | 4,416 | n/a |
| FYE Mar 2026 | n/a | n/a |
EPS earnings per share
FYE Mar 2026 -96.75¥
Change · 10 yrs −243.90¥
| Fiscal year | EPS ¥ | Basis |
|---|---|---|
| FYE Mar 2017 | 147.15 | Cons. |
| FYE Mar 2018 | 239.35 | Cons. |
| FYE Mar 2019 | 140.61 | Cons. |
| FYE Mar 2020 | 28.41 | Cons. |
| FYE Mar 2021 | 240.72 | Cons. |
| FYE Mar 2022 | 147.14 | Cons. |
| FYE Mar 2023 | 204.29 | Cons. |
| FYE Mar 2024 | 92.09 | Cons. |
| FYE Mar 2025 | 68.36 | Cons. |
| FYE Mar 2026 | -96.75 | Cons. |
BPS book value per share
FYE Mar 2026 n/a
Change · 9 yrs +1,893.67¥
| Fiscal year | BPS ¥ | Basis |
|---|---|---|
| FYE Mar 2017 | 2,465.42 | Cons. · IFRS |
| FYE Mar 2018 | 2,513.47 | Cons. · IFRS |
| FYE Mar 2019 | 3,311.16 | Cons. · IFRS |
| FYE Mar 2020 | 2,996.42 | Cons. · IFRS |
| FYE Mar 2021 | 3,281.58 | Cons. · IFRS |
| FYE Mar 2022 | 3,591.73 | Cons. · IFRS |
| FYE Mar 2023 | 4,015.76 | Cons. · IFRS |
| FYE Mar 2024 | 4,596.29 | Cons. · IFRS |
| FYE Mar 2025 | 4,359.08 | Cons. · IFRS |
| FYE Mar 2026 | n/a | Cons. · IFRS |
PER price-to-earnings ratio
FYE Mar 2026 n/a
Average · 9 yrs 41.94×
| Fiscal year | PER × | Basis |
|---|---|---|
| FYE Mar 2017 | 35.50 | Cons. |
| FYE Mar 2018 | 21.70 | Cons. |
| FYE Mar 2019 | 32.20 | Cons. |
| FYE Mar 2020 | 116.40 | Cons. |
| FYE Mar 2021 | 16.60 | Cons. |
| FYE Mar 2022 | 23.80 | Cons. |
| FYE Mar 2023 | 21.30 | Cons. |
| FYE Mar 2024 | 45.40 | Cons. |
| FYE Mar 2025 | 64.60 | Cons. |
| FYE Mar 2026 | n/a | Cons. |
PBR price-to-book ratio
FYE Mar 2026 n/a
Average · 9 yrs 1.31×
| Fiscal year | PBR × | Basis |
|---|---|---|
| FYE Mar 2017 | 2.15 | Cons. |
| FYE Mar 2018 | 2.03 | Cons. |
| FYE Mar 2019 | 1.36 | Cons. |
| FYE Mar 2020 | 1.09 | Cons. |
| FYE Mar 2021 | 1.21 | Cons. |
| FYE Mar 2022 | 0.96 | Cons. |
| FYE Mar 2023 | 1.06 | Cons. |
| FYE Mar 2024 | 0.90 | Cons. |
| FYE Mar 2025 | 1.00 | Cons. |
| FYE Mar 2026 | n/a | Cons. |
Workforce and productivity Headcount, pay and what each employee accounts for
Group employees
FYE Mar 2026 47,029people
Change · 10 yrs +17,129 people
| Fiscal year | Group employees people | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 29,900 | n/a | Cons. |
| FYE Mar 2018 | 27,230 | −8.9% | Cons. |
| FYE Mar 2019 | 49,578 | +82.1% | Cons. |
| FYE Mar 2020 | 47,495 | −4.2% | Cons. |
| FYE Mar 2021 | 47,099 | −0.8% | Cons. |
| FYE Mar 2022 | 47,347 | +0.5% | Cons. |
| FYE Mar 2023 | 49,095 | +3.7% | Cons. |
| FYE Mar 2024 | 49,281 | +0.4% | Cons. |
| FYE Mar 2025 | 47,455 | −3.7% | Cons. |
| FYE Mar 2026 | 47,029 | −0.9% | Cons. |
Parent-company employees
FYE Mar 2026 4,792people
Change · 10 yrs −1,846 people
| Fiscal year | Parent-company employees people | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 6,638 | n/a | Parent |
| FYE Mar 2018 | 5,461 | −17.7% | Parent |
| FYE Mar 2019 | 5,291 | −3.1% | Parent |
| FYE Mar 2020 | 5,350 | +1.1% | Parent |
| FYE Mar 2021 | 4,966 | −7.2% | Parent |
| FYE Mar 2022 | 5,149 | +3.7% | Parent |
| FYE Mar 2023 | 5,486 | +6.5% | Parent |
| FYE Mar 2024 | 5,474 | −0.2% | Parent |
| FYE Mar 2025 | 4,808 | −12.2% | Parent |
| FYE Mar 2026 | 4,792 | −0.3% | Parent |
Average annual pay parent company
FYE Mar 2026 ¥11.4m
Change · 10 yrs +¥1.3m
| Fiscal year | Average annual pay ¥ m | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 10.2 | n/a | Parent |
| FYE Mar 2018 | 10.4 | +2.3% | Parent |
| FYE Mar 2019 | 10.9 | +5.3% | Parent |
| FYE Mar 2020 | 10.9 | −0.3% | Parent |
| FYE Mar 2021 | 10.8 | −1.3% | Parent |
| FYE Mar 2022 | 11.1 | +2.6% | Parent |
| FYE Mar 2023 | 11.0 | −0.7% | Parent |
| FYE Mar 2024 | 10.8 | −1.4% | Parent |
| FYE Mar 2025 | 11.0 | +2.1% | Parent |
| FYE Mar 2026 | 11.4 | +3.7% | Parent |
Average age
FYE Mar 2026 44.0years
Change · 8 yrs +2.5 years
| Fiscal year | Average age years | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Parent |
| FYE Mar 2018 | n/a | n/a | Parent |
| FYE Mar 2019 | 41.5 | n/a | Parent |
| FYE Mar 2020 | 42.2 | +1.7% | Parent |
| FYE Mar 2021 | 42.0 | −0.5% | Parent |
| FYE Mar 2022 | 42.4 | +1.0% | Parent |
| FYE Mar 2023 | 42.8 | +0.9% | Parent |
| FYE Mar 2024 | 43.3 | +1.2% | Parent |
| FYE Mar 2025 | 43.4 | +0.2% | Parent |
| FYE Mar 2026 | 44.0 | +1.4% | Parent |
Average length of service
FYE Mar 2026 14.8years
Change · 10 yrs +0.1 years
| Fiscal year | Average length of service years | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 14.7 | n/a | Parent |
| FYE Mar 2018 | 14.5 | −1.4% | Parent |
| FYE Mar 2019 | 15.1 | +4.1% | Parent |
| FYE Mar 2020 | 15.0 | −0.7% | Parent |
| FYE Mar 2021 | 14.5 | −3.3% | Parent |
| FYE Mar 2022 | 14.2 | −2.1% | Parent |
| FYE Mar 2023 | 14.0 | −1.4% | Parent |
| FYE Mar 2024 | 14.6 | +4.3% | Parent |
| FYE Mar 2025 | 14.4 | −1.4% | Parent |
| FYE Mar 2026 | 14.8 | +2.8% | Parent |
Revenue per employee
FYE Mar 2026 ¥95.8m
Change · 10 yrs +¥37.9m
| Fiscal year | Revenue per employee ¥ m | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 57.9 | n/a | Cons. |
| FYE Mar 2018 | 65.0 | +12.2% | Cons. |
| FYE Mar 2019 | 42.3 | −34.9% | Cons. |
| FYE Mar 2020 | 69.3 | +63.8% | Cons. |
| FYE Mar 2021 | 67.9 | −2.0% | Cons. |
| FYE Mar 2022 | 75.4 | +11.0% | Cons. |
| FYE Mar 2023 | 82.0 | +8.8% | Cons. |
| FYE Mar 2024 | 86.5 | +5.5% | Cons. |
| FYE Mar 2025 | 96.5 | +11.6% | Cons. |
| FYE Mar 2026 | 95.8 | −0.8% | Cons. |
Operating profit per employee
FYE Mar 2026 ¥0.1m
Change · 9 yrs −¥8.7m
| Fiscal year | OP per employee ¥ m | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. |
| FYE Mar 2018 | 8.9 | n/a | Cons. |
| FYE Mar 2019 | 4.8 | −46.0% | Cons. |
| FYE Mar 2020 | 2.1 | −55.9% | Cons. |
| FYE Mar 2021 | 10.8 | +411.5% | Cons. |
| FYE Mar 2022 | 9.7 | −10.0% | Cons. |
| FYE Mar 2023 | 10.0 | +2.6% | Cons. |
| FYE Mar 2024 | 4.3 | −56.5% | Cons. |
| FYE Mar 2025 | 7.2 | +66.2% | Cons. |
| FYE Mar 2026 | 0.1 | −98.2% | Cons. |
Disclaimer
- Figures are reproduced as filed and are not restated: a change of accounting standard or of consolidation basis moves the series without anything happening to the business. Where that happened, the table says so in place of the year-on-year figure.
- Ratios and per-employee figures are computed from the filed lines rather than taken from the filing, and use year-end balances rather than averages.
Accuracy, liability, reuse and privacy — the full disclaimer →
Data API
Takeda Pharmaceutical’s history, presidents and financials
are published as static JSON — no key, plain GET. One API per
public page, and one per section where a page carries several tables.
Full specification →
/api/4502/company.json ·/api/4502/history.json ·/api/4502/ceo.json ·/api/4502/financials.json ·/api/4502/financials/segment.json ·/api/4502/financials/pl.json ·/api/4502/financials/cf.json ·/api/4502/financials/bs.json ·/api/4502/financials/employee.json ·/api/4502/financials/stock.json ·/api/4502/financials.csv ·/api/4502/financials_history.csv
/api/companies.json ·/api/decisions.json ·/api/api-manifest.json